Association testifies on behalf of amalgam

Gaithersburg, Md.—The ADA testified Tuesday before a U.S. Food and Drug Administration Advisory Panel tasked with assessing whether amalgam regulations issued in 2009 accurately represented the strengths and weaknesses of available data.